These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 33296791)

  • 1. Human apolipoprotein A-II reduces atherosclerosis in knock-in rabbits.
    Koike T; Koike Y; Yang D; Guo Y; Rom O; Song J; Xu J; Chen Y; Wang Y; Zhu T; Garcia-Barrio MT; Fan J; Chen YE; Zhang J
    Atherosclerosis; 2021 Jan; 316():32-40. PubMed ID: 33296791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scavenger receptor B1 (SR-B1) profoundly excludes high density lipoprotein (HDL) apolipoprotein AII as it nibbles HDL-cholesteryl ester.
    Gillard BK; Bassett GR; Gotto AM; Rosales C; Pownall HJ
    J Biol Chem; 2017 May; 292(21):8864-8873. PubMed ID: 28373285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of human apoAII in transgenic rabbits leads to dyslipidemia: a new model for combined hyperlipidemia.
    Koike T; Kitajima S; Yu Y; Li Y; Nishijima K; Liu E; Sun H; Waqar AB; Shibata N; Inoue T; Wang Y; Zhang B; Kobayashi J; Morimoto M; Saku K; Watanabe T; Fan J
    Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2047-53. PubMed ID: 19778946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of apolipoprotein composition of high density lipoprotein particles on cholesteryl ester transfer protein activity. Particles containing various proportions of apolipoproteins AI and AII.
    Lagrost L; Perségol L; Lallemant C; Gambert P
    J Biol Chem; 1994 Feb; 269(5):3189-97. PubMed ID: 8106353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of apolipoprotein AII in transgenic mice converts high density lipoproteins to proinflammatory particles.
    Castellani LW; Navab M; Van Lenten BJ; Hedrick CC; Hama SY; Goto AM; Fogelman AM; Lusis AJ
    J Clin Invest; 1997 Jul; 100(2):464-74. PubMed ID: 9218525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the carboxy-terminal domain of human apolipoprotein AI in high-density-lipoprotein metabolism--a study based on deletion and substitution variants in transgenic mice.
    Holvoet P; Danloy S; Collen D
    Eur J Biochem; 1997 May; 245(3):642-7. PubMed ID: 9183000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of myeloperoxidase-induced apoAI-apoAII heterodimers in high-density lipoprotein.
    Kameda T; Usami Y; Shimada S; Haraguchi G; Matsuda K; Sugano M; Kurihara Y; Isobe M; Tozuka M
    Ann Clin Lab Sci; 2012; 42(4):384-91. PubMed ID: 23090734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced cholesterol efflux by tyrosyl radical-oxidized high density lipoprotein is mediated by apolipoprotein AI-AII heterodimers.
    Wang WQ; Merriam DL; Moses AS; Francis GA
    J Biol Chem; 1998 Jul; 273(28):17391-8. PubMed ID: 9651324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Moderate red wine consumption in healthy volunteers reduced plasma clearance of apolipoprotein AII.
    Gottrand F; Beghin L; Duhal N; Lacroix B; Bonte JP; Fruchart JC; Luc G
    Eur J Clin Invest; 1999 May; 29(5):387-94. PubMed ID: 10354195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human apolipoprotein A-II protects against diet-induced atherosclerosis in transgenic rabbits.
    Wang Y; Niimi M; Nishijima K; Waqar AB; Yu Y; Koike T; Kitajima S; Liu E; Inoue T; Kohashi M; Keyamura Y; Yoshikawa T; Zhang J; Ma L; Zha X; Watanabe T; Asada Y; Chen YE; Fan J
    Arterioscler Thromb Vasc Biol; 2013 Feb; 33(2):224-31. PubMed ID: 23241412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein CIII Deficiency Protects Against Atherosclerosis in Knockout Rabbits.
    Yan H; Niimi M; Matsuhisa F; Zhou H; Kitajima S; Chen Y; Wang C; Yang X; Yao J; Yang D; Zhang J; Murakami M; Nakajima K; Wang Y; Liu E; Liang J; Chen YE; Fan J
    Arterioscler Thromb Vasc Biol; 2020 Sep; 40(9):2095-2107. PubMed ID: 32757647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholesterol mobilization by free and lipid-bound apoAI(Milano) and apoAI(Milano)-apoAII heterodimers.
    Wang WQ; Moses AS; Francis GA
    Biochemistry; 2001 Mar; 40(12):3666-73. PubMed ID: 11297434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidation of high density lipoproteins. II. Evidence for direct reduction of lipid hydroperoxides by methionine residues of apolipoproteins AI and AII.
    Garner B; Waldeck AR; Witting PK; Rye KA; Stocker R
    J Biol Chem; 1998 Mar; 273(11):6088-95. PubMed ID: 9497326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spectrum of Apolipoprotein AI and Apolipoprotein AII Proteoforms and Their Associations With Indices of Cardiometabolic Health: The CARDIA Study.
    Wilkins JT; Seckler HS; Rink J; Compton PD; Fornelli L; Thaxton CS; LeDuc R; Jacobs D; Doubleday PF; Sniderman A; Lloyd-Jones DM; Kelleher NL
    J Am Heart Assoc; 2021 Sep; 10(17):e019890. PubMed ID: 34472376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Arg123-Tyr166 central domain of human ApoAI is critical for lecithin:cholesterol acyltransferase-induced hyperalphalipoproteinemia and HDL remodeling in transgenic mice.
    Holvoet P; De Geest B; Van Linthout S; Lox M; Danloy S; Raes K; Collen D
    Arterioscler Thromb Vasc Biol; 2000 Feb; 20(2):459-66. PubMed ID: 10669644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholesterol efflux, lecithin-cholesterol acyltransferase activity, and pre-beta particle formation by serum from human apolipoprotein A-I and apolipoprotein A-I/apolipoprotein A-II transgenic mice consistent with the latter being less effective for reverse cholesterol transport.
    Castro G; Nihoul LP; Dengremont C; de Geitère C; Delfly B; Tailleux A; Fievet C; Duverger N; Denèfle P; Fruchart JC; Rubin EM
    Biochemistry; 1997 Feb; 36(8):2243-9. PubMed ID: 9047326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the structural and functional effects of monomeric and dimeric human apolipoprotein A-II in high density lipoprotein particles.
    Lund-Katz S; Murley YM; Yon E; Gillotte KL; Davidson WS
    Lipids; 1996 Nov; 31(11):1107-13. PubMed ID: 8934442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein AII enrichment of HDL enhances their affinity for class B type I scavenger receptor but inhibits specific cholesteryl ester uptake.
    Pilon A; Briand O; Lestavel S; Copin C; Majd Z; Fruchart JC; Castro G; Clavey V
    Arterioscler Thromb Vasc Biol; 2000 Apr; 20(4):1074-81. PubMed ID: 10764676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deficiency of Cholesteryl Ester Transfer Protein Protects Against Atherosclerosis in Rabbits.
    Zhang J; Niimi M; Yang D; Liang J; Xu J; Kimura T; Mathew AV; Guo Y; Fan Y; Zhu T; Song J; Ackermann R; Koike Y; Schwendeman A; Lai L; Pennathur S; Garcia-Barrio M; Fan J; Chen YE
    Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1068-1075. PubMed ID: 28428219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Saturated fatty acid, but not cholesterol, regulates apolipoprotein AI gene expression by posttranscriptional mechanism.
    Srivastava RA
    Biochem Mol Biol Int; 1994 Sep; 34(2):393-402. PubMed ID: 7849650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.